Xeomin ® (incobotulinumtoxinA) is now available to healthcare providers in the US in three single-dose vial sizes: 50 unit, 100 unit and 200 unit, with the same price per toxin unit for all three ...
Please provide your email address to receive an email when new articles are posted on . Xeomin is the first neurotoxin that can simultaneously treat frown lines, forehead lines and crow’s feet. Xeomin ...
GREENSBORO, N.C., Aug. 2 /PRNewswire/ -- Merz Pharmaceuticals today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin® (incobotulinumtoxinA), a botulinum ...
The new approval expands Xeomin’s indications to include horizontal forehead lines and lateral canthal lines. The FDA has approved Merz Aesthetics’ Xeomin (incobotulinumtoxinA) as the first and only ...
Merz North America announced that Xeomin (incobotulinumtoxinA) has been approved by the Food and Drug Administration (FDA) for the treatment of upper limb spasticity in adults. Merz North America ...
While fine lines and wrinkles are completely normal and something everyone experiences as they age, some prefer a smoother, line-free complexion. To achieve those results, many turn to at-home ...
The sBLA approval was based on data from a phase 3 study evaluating Xeomin in 216 patients aged 6 to 17 years with chronic sialorrhea associated with cerebral palsy, other genetic or congenital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results